The Blavatnik Fellowship in Life Science Entrepreneurship offers Harvard Business School (HBS) alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new ventures around promising life science technologies and develop their leadership talents during a 12-month fellowship year. This unique opportunity allows fellows to work closely with the leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of life science entrepreneurs.
Since its founding in 2013, the Fellowship has supported 59 fellows who have launched 50 science-based companies and collectively raised more than $550 million in funding. This total excludes a successful IPO by a program alumnus in June 2020 that raised an additional $244 million. These ventures span transformative areas including neuroscience, diagnostics, aging, and health care access, reflecting the program’s focus on ambitious, outcomes-driven entrepreneurship. The 12th cohort, consisting of five fellows, began in July 2025.
2025–26 Blavatnik Fellows
Erik Aznauryan
Joseph Sedlak
Christina Vosbikian
Cody Tranbarger
Oliver Weisser
Learn about the current and past Blavatnik Fellows in Life Science Entrepreneurship
The program is directed by Tracy Perry, Blavatnik Fellowship Administrative Director, and guided by the Blavatnik Life Science Entrepreneurship Council, a network of experienced operators, investors, and scientists who help shape fellows’ ventures and accelerate their path to impact. Supporting Blavatnik fellows in their pursuit of successful enterprise creation, the program provides practical materials for entrepreneurship—time, working space, operating funds— with access to strategic resources—mentorship, networking, and workshops with industry experts. Companies started by Blavatnik Fellows span innovative life science categories including vision and hearing impairment, women’s health, aging, sports medicine, diagnostics, neuroscience, and health care access.